news El Financiero 2026-08-20

Moderna and Merck report progress on personalized cancer vaccine

Moderna and Merck announced positive preliminary results for a Phase III clinical trial of an experimental personalized mRNA cancer vaccine for melanoma patients.

Support Your Local Toad

The Pesky Toad is free and ad-light. If you find it useful, toss a few pesos in the tip jar to help keep the servers running and the satire flowing.

$

MXN · Minimum $10